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Purpose: The purpose of this report is to describe the contact lens deposition proteome associated with two silicone
hydrogel contact lenses and care solutions using a mass spectrometric-based approach.
Methods: This was a randomized, controlled, examiner-masked crossover clinical trial that included 48 participants.
Lenses and no-rub care solutions evaluated included galyfilcon A (Acuvue Advance, Vistakon Inc., Jacksonville, FL),
lotrafilcon B (O2 Optix, CIBA Vision Inc., Duluth, GA), AQuify (CIBA Vision Inc.), and ReNu MoistureLoc (Bausch
and Lomb Inc., Rochester, NY). After two weeks of daily wear in each lens-solution combination, the left lens was removed
by the examiner (using gloves and forceps) and placed in a protein precipitation buffer (acetone). The precipitate was
quantitated for total protein concentration (per lens), and proteins were then identified using liquid chromatography tandem
mass spectrometry (nano-LC-MS/MS) and peptide sequencing.
Results: Between 7.32 and 9.76 µg/lens of protein was observed on average from each lens-solution combination. There
were 19 total unique proteins identified across the two lens materials, and six proteins were identified in all four lens-
solution combinations including lipocalin, lysozyme, lacritin, lactoferrin, proline rich 4, and Ig Alpha. Lotrafilcon B was
associated with 15 individual proteins (across both care solutions), and 53% of these proteins were observed in at least
50% of the analyses. Galyfilcon A was associated with 13 individual proteins, and 38.5% of these proteins were observed
in at least 50% of the analyses. There were three unique proteins identified from galyfilcon A and four unique proteins
identified from lotrafilcon B.
Conclusions: The total amount of proteins identified from silicone hydrogel materials is much less than the amount from
traditional soft lens materials. For the most part, the deposition proteome across these lenses is similar, although the
different polymer characteristics might be associated with some variability in observance of the less frequently identified
proteins.
Deposition of tear film components on contact lenses has
been known for many years. Deposition is typically thought
of as being different from a biofilm or pellicle. A bioflim or
pellicle is a normal physiologic coating over the surface of a
biomaterial whereas deposition should be considered a more
significant and potentially pathological finding on a contact
lens [1,2]. Short-term deposition-related complications may
be relatively harmless with occasional symptoms of
discomfort or visual disturbances [3,4]. Longer-term deposit-
related complications could impact ocular health (for
example, inflammatory responses such as contact lens
papillary conjunctivitis) [5-8].
Deposition occurs across lens materials despite attempts
to improve cleaning regimens or modify polymer materials
and wear schedules. The quantity and composition of contact
lens deposition is influenced by the material characteristics
based on the Food and Drug Administration (FDA)
categorization and species of interest (for example, lipid,
protein, or inorganic). In terms of protein deposition, it is
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generally recognized that FDA group IV materials deposit the
greatest amount of protein (up to approximately 1,000 μg/
lens) while FDA Group I materials deposit the least protein
(up to approximately 10–20 μg/lens) [9-17]. Ionic and higher
water content materials tend to attract more protein than
nonionic materials [10,14,15,17-23]. Recent work on silicone
hydrogels has shown that these lenses deposit up to about
10 μg per lens, although this has not been extensively studied
ex vivo [24-29].
In terms of the composition of protein deposition
associated with contact lens materials, most of the work has
centered around lysozyme using chromatographic or assay
based methods [12,16,20,24,26,27,30-34]. Initial work via
mass spectrometry was done by matrix-assisted laser
desorption ionization (MALDI) mass spectrometry, although
identifications of each species in the proteome were not
conducted [20,35,36]. Today’s more sophisticated analytical
techniques are likely to change our idea of the contact lens-
related deposition proteome present. In this regard,
contemporary analytical techniques could provide a more
comprehensive understanding of the deposition proteome
across polymer materials, care solutions, and wear schedules.
The primary aim of this work was to use a mass spectrometry-
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291based approach to evaluate the contact lens deposition
proteome associated with two daily wear silicone hydrogel
contact lenses when used with two multipurpose care
solutions.
METHODS
General study design and patient sample: This was a
randomized, controlled, examiner-masked, crossover clinical
trial. The protocol was approved by the University
Institutional Review Board according to the tenets of the
Declaration of Helsinki, and all subjects gave their informed
and written consent. Following consent, study criteria were
reviewed with each subject. Subjects were required to be 18
years of age or older, have 20/40 visual acuity with habitual
contact lenses, have “healthy” eyes (taking no ocular
medications), have a refractive error between –1.00DS and –
6.00DS (and < 1.00 DC), and be a current silicone hydrogel
lens wearer (daily wear only, seven days per week, 12 h per
day for at least one month).
The two lenses used in this study were galyfilcon A
(Acuvue Advance, Vistakon Inc., Jacksonville, FL) and
lotrafilcon B (O2 Optix, CIBA Vision Inc., Duluth, GA), and
the two care systems used in the study were AQuify (CIBA
Vision Inc.) and ReNu with MoistureLoc (Bausch and Lomb
Inc., Rochester, NY). Table 1 provides details of the
composition of each material and lens care solution. All lens
and care solution combinations (i.e., four treatment
combinations given the number of lens-solution
combinations) were randomly assigned to subjects who wore
the lenses on a daily basis for 14–17 days and used the care
solutions as indicated by their respective manufacturer (i.e.,
no rub, rinse only). Subjects returned after each combination
for an outcome visit when contact lenses were removed as
described below.
Lens collection and sample pooling: The masked examiner
wore latex-free gloves and used ophthalmic tweezers to
remove the lenses from the eyes of subjects. Lenses from the
left eyes of subjects were then placed directly in a protein
precipitation buffer for subsequent proteomic analysis
(described below). Lenses were not rinsed before storage. Six
individual subject samples were pooled in composites within
each treatment combination (lens-solution combination).
Thus, for each lens-solution treatment combination (for which
all 48 subjects experienced), a set of eight composites was
obtained for analyses.
Protein precipitation from contact lenses and quantitation:
Each sample was mixed with acetone at –20 °C at a ratio of
1:10 sample/acetone and precipitated overnight at –20 °C.
This was then centrifuged at room temperature for 10 min, the
supernatant was removed, and it was repeated a second time.
The samples were allowed to air dry for approximately 15 min
before re-suspending them in water.
The proteins were quantitated using the Bradford Assay
(reported in µg/lens for each lens-solution combination). A
stock solution of BSA (250 µg/ml or 500 µg/ml) using Pierce
BSA stock solution was prepared in water, and 30 µl of the
TABLE 1. COMPONENTS OF CONTACT LENS POLYMERS AND CARE SOLUTIONS USED IN THE STUDY.
Device or Care Solution Composition
AQuify Multi-Purpose Care Solution Sorbitol
Tromethamine
Pluronic F127
Sodoum phosphate dihydrogen
Dexpanthnol
Edetate disodium diohydrate
Polyhexanide 0.0001
ReNU MoistureLoc Care Solution Alexidine
Borid acid
Sodium chloride
Sodium phosphate
Hydranate
Tetronic 1107
Poloxamer 407
Polyquarternium 10
Acuvue Advance (contact lens) Monofunctional polydimethylsiloxane (MPDS)
“N,N-dimethylacrylamide (DMA)”
Ethyleneglycol dimethacrylate (EGDMA)
Poly-2-hydroxyethyl methacrylate (pHEMA)
Polyvinyl pyrrolidone (PVP)
Siloxane macromer
O2 Optix (contact lens) “N,N-dimethylacrylamide (DMA)”
Tris-(trimethylsiloxysilyl) propylvinyl carbamate
Siloxane macromer
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and mixed. The mixture (25 ng/µl BSA) was then allowed to
equilibrate for 10 min and was used to create a standard curve.
A blank reading using a spectrophotometer was obtained
using 90 µl of Bradford reagent at an absorbance of 595 nm.
Next, 10 µl of the BSA/Bradford dye solution was added to
the Bradford reagent and thoroughly mixed, and the
absorbance was read. This was repeated at least 10 more times
to generate a set of concentration standards and a calibration
curve.
Sample (1 μl) and 9 µl of water were added to 90 µl of
Bradford reagent and allowed to equilibrate for 10 min. The
sample absorbance was read to the second decimal place using
the spectrophotometer, and the process was repeated two more
times. The calibration curve data was used to calculate the
sample concentration, and the protein concentration was
calculated by multiplying the dilution factor used for the
assay. This method is generally linear up to 15 µg/ml, and the
minimum accurate concentration reading is approximately 1
µg/ml. The final protein concentration is reported in µg/lens
for each lens-solution combination.
Trypsin digestion and protein identification: Protein (5 µg)
from each pooled composite was digested using trypsin [37].
Nano-liquid chromatography tandem mass spectrometry
(nano-LC-MS/MS) was performed on a Thermo Finnigan
LTQ mass spectrometer. The LC system was an UltiMate™
Plus system from LC-Packings A Dionex Co. (Sunnyvale,
CA). The scan sequence of the mass spectrometer was based
on the TopTen™ method using dynamic exclusion. Sequence
information from the MS/MS data was processed by
converting the raw data (.dta) files into a merged file (.mgf)
using MGF creator (merge.pl, a Perl script). The resulting mgf
files were searched using Mascot Daemon by Matrix Science
(Boston, MA). Protein identification was confirmed on a
minimum of two sequenced tryptic peptides with a minimum
string of five amino acids [38,39]. Assigned peaks had a
minimum of 10 counts (signal:noise of three). The mass
accuracy of the precursor ions was set to 1.8 Da and the
fragment mass accuracy was set to 0.5 Da. Considered
modifications (variable) included methionine oxidation and
carbamidomethyl cysteine.
Statistical analyses: Protein quantitation results were
compared across treatment combinations using nonparametric
ANOVA (Friedman’s test) with Dunn’s multiple comparison
post-hoc test as appropriate. Protein identification results were
tabulated, whereby the frequency of each individual protein
was determined across the eight composites within each
combination. An arbitrary a priori decision to include
frequently observed proteins was based on the number of
composites (out of eight) in which the unique protein was
identified. In this regard, a protein was considered to be
frequently observed if it was observed in at least 50% of the
composites.
RESULTS
Protein quantitation: Due to a technical difficulty, the first
composite of eight lenses was not able to be quantitated due
to an inefficient extraction complication (although
information about protein identification was obtained from
this composite). There were different protein concentrations
across lens-care solution combinations (Friedman’s
statistic=9.00, p=0.02). Galyfilcon A was generally associated
with slightly less total protein than lotrafilcon B regardless of
care solution (1.71 µg/lens less on average than lotrafilcon B).
Galyfilcon A lenses showed an average protein quantitation
of 8.78 ± 1.49 µg/lens (median=8.70 µg/lens) with AQuify
and 7.32 ± 0.90 µg/lens (median=7.45 µg/lens) with ReNu
MoistureLoc. Lotrafilcon B lenses showed an average protein
quantitation of 9.75 ± 1.43 µg/lens (median=10.00 µg/lens)
with AQuify and 9.76 ± 0.96 µg/lens (median=10.01 µg/lens)
with ReNu MoistureLoc. Post-hoc testing revealed
significantly less total protein content in galyfilcon A when
compared to either lotrafilcon B with AQuify or lotrafilcon B
with Renu (both p<0.05); no other post-hoc comparisons
differed significantly.
Protein identifications (nano-LC-MS/MS): Table 2 lists the
proteins identified from the eight composites within each lens-
solution combination (again, each was a pooled sample of six
lenses). Overall, 13 proteins were identified from galyfilcon
B while 15 proteins were observed from lotrafilcon B. The
following six proteins were identified in all four lens-solution
combinations of the trial (reported by relative frequency of
observance in terms of the number of composites in which the
protein was observed): lipocalin (the most frequently
observed), lysozyme, lacritin, lactoferrin, proline rich 4, and
Ig Alpha. The following three proteins were identified in three
of the four lens-care solution combinations of the trial
(reported by relative frequency of observance in terms of the
number of composites in which it was observed): Ig Kappa,
secretoglobin 2A1, and prolactin induced protein.
When evaluating proteins extracted from the ReNu
combinations of the trial, lipocalin was observed in all eight
composites for both galyfilcon A and lotrafilcon B while none
of the proteins were observed in all eight composites when
evaluating those associated with AQuify. When AQuify was
used with galyfilcon A, lipocalin was identified in five of the
eight composites, and when AQuify was used with lotrafilcon
B, lipocalin was observed in seven of the eight composites.
Lotrafilcon B lenses with either care solution (AQuify or
ReNu) were associated with a total of 15 individual proteins
observed over all composites, and eight (53.3%) of these
proteins were observed in at least four (50%) of the
composites. Galyfilcon A lenses were associated with a total
of 13 proteins (again, regardless of the care solution), and five
(38.5%) of these proteins were observed in 50% of the
composites. There were two unique proteins identified from
galyfilcon A only (basic proline rich protein and heat shock
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lotrafilcon B only (secretoglobin family 2A member 2, Ig
Lambda, Zn alpha 2 glycoprotein, and secretoglobin 1D1).
DISCUSSION
To our knowledge, this work represents one of the first reports
of the use of mass spectrometry (specifically nano-LC-MS/
MS and bioinformatics) to explore the contact lens-related
proteome. Gel chromatography or assay based methods have
traditionally been used when evaluating proteins associated
with contact lenses, and much work has centered primarily on
lysozyme [17,19,20,24,26,27,30-33,36,40-46]. However,
recent reports using mass-spectrometry based methods have
shown the number of proteins associated with the tear film
range into the hundreds [47-49]. Certainly, lysozyme and
other traditionally understood proteins such as lactoferrin,
lipocalin, and albumin continue to be identified in the tear film
(as most were here), but the extent of our knowledge of the
tear film proteome has lead to new insights into fundamental
processes and proteins present both in health- and disease-
related states. It is important that we also extend our
knowledge and fundamental understanding of the proteome
typically associated with hydrogel lens wear to further
identify the role these proteins may have in the continued safe,
comfortable wear of contact lenses.
TABLE 2. PROTEIN IDENTIFICATIONS AND THE FREQUENCY OF OBSERVANCE OF THE PROTEIN RELATIVE TO THE EIGHT COMPOSITES ANALYZED
PER COMBINATION.
Frequency (out of 8
composites)
Acuvue Advance &
AQuify
Acuvue Advance & ReNu O2 Optix & Aquify O2 Optix & ReNu
8 Lipocalin (LCN1) Lipocalin (LCN1)
7 Lipocalin (LCN1) Lacritin (LACRT)
6 Lysozyme (LYZ) Lysozyme (LYZ)
5 Lipocalin (LCN1) Lysozyme (LYZ) Lactoferrin (LTF) Proline Rich 4 (PRR4)
Lysozyme (LYZ) Proline Rich 4 (PRR4)
4 Lactoferrin (LTF) Ig Alpha (CD79A) Ig Kappa (IGKC)
Lacritin (LACRT) Secretoglobin 2A1
(SCGB2A1)
Lactoferrin (LTF)
Ig Alpha (CD79A) Lacritin (LACRT)
3 Lactoferrin (LTF) Cystatin SN (CST1) Prolactin Induced Protein
(PIP)
Lacritin (LACRT) Secretoglobin 2A1
(SCGB2A1)
Proline Rich 4 (PRR4)
2 Ig Alpha (CD79A) Secretory Component
(ECM1)
Prolactin Induced Protein
(PIP)
Ig Alpha (CD79A)
Proline Rich 4 (PRR4)
Secretoglobin 2A1
(SCGB2A1)
Prolactin Induced Protein
(PIP)
1 Ig Kappa (IGKC) Carbonly Reductase
(CBR1)
Secretoglobin 2A2
(SCGB2A2)
Secretoglobin 2A2
(SCGB2A2)
Secretoglobin 2A1 Secretoglobin 1D1
(SCGB1D1)
Secretoglobin 1D1
(SCGB1D1)
(SCGB2A1) Ig Kappa (IGKC) Ig Lambda (IGLC2)
Secretory Component
(ECM1)
Zn alpha 2 glycoprotein
(AZGP1)
Carbonyl Reductase
(CBR1)
Basic Proline Rich
(PROL1)
Heat shock Protein 27
(HSPBAP1)
Total proteins per arm 11 11 13 13
Total unique proteins per
material
13 15
Note that the gene symbol for each protein is provided in parentheses. Secretoglobin 2A1 is also known as mammaglobin B.
Secretoglobin 2A2 is also known as mammaglobin A. Secretoglobin 1D1 is also known as lipophilin A.
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observed across all material/care solution treatment
combinations in this trial (lipocalin, lysozyme, lacritin,
lactoferrin, proline rich 4, and Ig Alpha), and there were
another three that were observed in three of the four lens-care
solution combinations (Ig Kappa, secretoglobin 2A1, and
prolactin induced protein). Thus, these nine proteins appear
to make up the bulk of the contact lens-related proteome
associated with these two silicone hydrogel materials. It
should be noted that these results are relevant to this particular
precipitation buffer (acetone); in this regard, the use of any
buffer may differ for different lens materials. This is likely not
the case though for the small differences in protein
quantitation found here but may be associated with
differences in the infrequently observed unique proteins.
It was also observed that the more frequently observed
(possibly higher abundant) proteins from both lens material
types seem to be fairly consistent as the same proteins were
generally observed regardless of the different care solutions
for each lens material. This is true even though the care
solutions differ in terms of their composition, although
differences in their composition may be related to the
identification of some of the more infrequently observed
proteins. The lotrafilcon B material with either care solution
was associated with a total of 15 unique proteins observed
over all analyses with eight (53.3%) of these proteins being
observed in at least one half of the analyses. Similarly,
galyfilcon A lenses were associated with a total of 13 unique
proteins (again, regardless of the care solution), and five
(38.5%) of these proteins were observed in one half of the
analyses. The five commonly observed proteins (i.e.,
observed at least 50% of the time for both material types) were
lipocalin, lysozyme, lactoferrin, lacritin, and Ig Alpha. The
proteome observed from the lotrafilcon B lenses showed
slightly more diversity in the frequency of the observed
proteins (i.e., observed more than 50% of the time but only
from the lotrafilcon material) and also included proline rich
4, secretoglobin 2A1, and Ig Kappa. As these proteins are
commonly observed in the tear film, it could be that these
proteins are more strongly bound to the galyfilcon A material
thus more difficult to extract from the lens; alternatively, they
may not have an affinity for galyfilcon A itself, although this
seems unlikely. Although lotrafilcon B was associated with
slightly higher total quantities of proteins than the galyfilcon
A lenses (~1.7 µg/lens), it is highly unlikely that this
difference has any clinical relevance. It could be that
lotrafilcon B inherently binds more proteins than galyfilcon
A or that both materials have a similar affinity for tear film
proteins, but galyfilcon A binds the proteins more strongly,
making their removal more difficult with a no-rub
multipurpose care solution. It is not likely that there are
differences in the efficacy of the two care solutions as very
similar levels of total proteins were extracted within each
material. However, it is important to emphasize that the total
protein quantities from each lens materials, nor the differences
between the lens materials, are not likely associated with any
clinical impact on lens performance (i.e., fitting
characteristics, visual performance, or subjective outcomes).
This is particularly true for FDA Group IV lenses as they are
known to deposit massive amounts of total protein (up to
1,000 µg/lens), yet these lenses have been clinically used quite
successfully for years. Rather, the identification of individual
proteins associated with these contact lenses may lend itself
to a broader fundamental understanding of the impact of
contact lenses on ocular surface/tear film physiology itself.
While clinical outcomes could be related to the total protein
quantity, another consideration is the conformational state of
the proteins (such as tertiary versus denatured), which was not
studied in the present work [50].
There were also some unique proteins identified from
both galyfilcon A and lotrafilcon B (although infrequently
observed). For instance, heat shock protein 27 (associated
with thermal upregulation associated with stress response
[51]), basic proline rich protein (with anti-viral, among other
properties [52,53]), and the secretory component were
associated with galyfilcon A. Interestingly, the secretory
component was associated with galyfilcon A with both care
solutions, although this was not associated with lotrafilcon B.
Likewise, cystatin S1 (cysteine protease inhibitor [54]), Ig
lambda, and secretoglobin 1D1 were associated with
lotrafilcon B but not galyfilcon A. It is important to note that
lenses were not rinsed following removal from the eye, which
might remove the more extraneous proteins that are not
necessarily bound to the material itself. This certainly could
impact the proteins that are observed, in particular for the
aforementioned less commonly observed proteins. In this
regard, some proteins that are associated with the lens but not
necessarily bound to it may be observed due to things like the
lens removal process itself, surface area differences, surface
tension differences, or other extraneous factors; however, if
this were the case, it would seem that we would identify
numerous proteins given the vast quantity of proteins
identified in the tear film itself. There was no adaptation
period for subjects entering the study, and each was required
to have at least one month of silicone hydrogel lens wear.
Thus, it could be possible that experience with new lens
materials lead to differences in proteins that were expressed
(or not expressed). However, the approach used probably
allows the most global assessment of the entire lens-related
proteome as not all patients rinse their lenses before storage.
Thus, the approach presented here might be reflective of the
proteome associated with this clinical situation.
In summary, the quantities of proteins associated with
silicone hydrogels are fairly minimal compared to traditional
soft lens materials. While there are small differences, it is
unlikely that these differences impact clinical performance.
The contact lens deposition proteome appears to be fairly
consistent between these two silicone hydrogels which consist
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lactoferrin, proline rich 4, and Ig Alpha. However, unique
proteins were observed from each polymer type, and while it
is not expected that these differences would have an impact
on the clinical level per se, they do yield insight into the tear
film proteome itself as well as the way in which these
polymers interact with the tear film proteome.
ACKNOWLEDGMENTS
We wish to acknowledge Richard J. Sessler, MS for his
assistance with this work. CIBA Vision Inc. provided the
funding for this study.
Disclosure: Dr. Green-Church has received research funding
from Alcon, Inc. Dr. Nichols has received research or travel
funding from Allergan, Inc, CIBA Vision, Vistakon, Inc,
Alcon, Inc, Advanced Medical Optics, Inc, and Menicon, Inc.
REFERENCES
1. Hart DE, Plociniak MP, Grimes GW. Defining the
physiologically normal coating and pathological deposit: an
analysis of sulfur-containing moieties and pellicle thickness
on hydrogel contact lenses. CLAO J 1998; 24:85-101. [PMID:
9571268]
2. Hart DE. Influence of contact lens material surface
characteristics and replacement frequency on protein and
lipid deposition. Optom Vis Sci 1999; 76:616-7. [PMID:
10498001]
3. Gellatly KW, Brennan NA, Efron N. Visual decrement with
deposit accumulation of HEMA contact lenses. Am J Optom
Physiol Opt 1988; 65:937-41. [PMID: 3265595]
4. Jones L, Franklin V, Evans K, Sariri R, Tighe B. Spoilation and
clinical performance of monthly vs. three monthly Group II
disposable contact lenses. Optom Vis Sci 1996; 73:16-21.
[PMID: 8867677]
5. Refojo MF, Holly FJ. Tear protein adsorption on hydrogels: a
possible cause of contact lens allergy. Contact Intraocul Lens
Med J 1977; 3:23-35.
6. Suttorp-Schulten MS, Luyendijk L, Kok JH, Kijlstra A. HPLC
analysis of tear proteins in giant papillary conjunctivitis. Doc
Ophthalmol 1989; 72:235-40. [PMID: 2625085]
7. Richard NR, Anderson JA, Tasevska ZG, Binder PS. Evaluation
of tear protein deposits on contact lenses from patients with
and without giant papillary conjunctivitis. CLAO J 1992;
18:143-7. [PMID: 1499118]
8. Meisler DM, Keller WB. Contact lens type, material, and
deposits and giant papillary conjunctivitis. CLAO J 1995;
21:77-80. [PMID: 7712614]
9. Minarik L, Rapp J. Protein deposits on individual hydrophilic
contact lenses: effects of water and ionicity. CLAO J 1989;
15:185-8. [PMID: 2776287]
10. Minno GE, Eckel L, Groemminger S, Minno B, Wrzosek T.
Quantitative analysis of protein deposits on hydrophilic soft
contact lenses: I. Comparison to visual methods of analysis.
II. Deposit variation among FDA lens material groups. Optom
Vis Sci 1991; 68:865-72. [PMID: 1766648]
11. Lin ST, Mandell RB, Leahy CD, Newell JO. Protein
accumulation on disposable extended wear lenses. CLAO J
1991; 17:44-50. [PMID: 2007285]
12. Jones L, Evans K, Sariri R, Franklin V, Tighe B. Lipid and
protein deposition of N-vinyl pyrrolidone-containing group
II and group IV frequent replacement contact lenses. CLAO
J 1997; 23:122-6. [PMID: 9108978]
13. Prager MD, Quintana RP. Radiochemical studies on contact
lens soilation. II. Lens uptake of cholesteryl oleate and
dioleoyl phosphatidylcholine. J Biomed Mater Res 1997;
37:207-11. [PMID: 9358313]
14. Maissa C, Franklin V, Guillon M, Tighe B. Influence of contact
lens material surface characteristics and replacement
frequency on protein and lipid deposition. Optom Vis Sci
1998; 75:697-705. [PMID: 9778704]
15. Tighe BJ, Jones L, Evans K, Franklin V. Patient-dependent and
material-dependent factors in contact lens deposition
processes. Adv Exp Med Biol 1998; 438:745-51. [PMID:
9634963]
16. Jones L, Mann A, Evans K, Franklin V, Tighe B. An in vivo
comparison of the kinetics of protein and lipid deposition on
group II and group IV frequent-replacement contact lenses.
Optom Vis Sci 2000; 77:503-10. [PMID: 11100888]
17. McArthur SL, McLean KM, St John HA, Griesser HJ. XPS and
surface-MALDI-MS characterisation of worn HEMA-based
contact lenses. Biomaterials 2001; 22:3295-304. [PMID:
11700801]
18. Sack RA, Jones B, Antignani A, Libow R, Harvey H. Specificity
and biological activity of the protein deposited on the
hydrogel surface. Relationship of polymer structure to biofilm
formation. Invest Ophthalmol Vis Sci 1987; 28:842-9.
[PMID: 3570694]
19. Garrett Q, Garrett RW, Milthorpe BK. Lysozyme sorption in
hydrogel contact lenses. Invest Ophthalmol Vis Sci 1999;
40:897-903. [PMID: 10102286]
20. Soltys-Robitaille CE, Ammon DM Jr, Valint PL Jr, Grobe GL
3rd. The relationship between contact lens surface charge and
in-vitro protein deposition levels. Biomaterials 2001;
22:3257-60. [PMID: 11700797]
21. Hart DE. Surface interactions on hydrogel contact lenses:
scanning electron microscopy (SEM). J Am Optom Assoc
1987; 58:962-74. [PMID: 3480910]
22. Jones B, Sack R. Immunoglobulin deposition on soft contact
lenses: relationship to hydrogel structure and mode of use and
giant papillary conjunctivitis. CLAO J 1990; 16:43-8. [PMID:
2407379]
23. Tripathi RC, Tripathi BJ, Ruben M. The pathology of soft
contact lens spoilage. Ophthalmology 1980; 87:365-80.
[PMID: 7402583]
24. JonesLSenchynaMGlasierMASchicklerJForbesILouieDMayC
Lysozyme and lipid deposition on silicone hydrogel contact
lens materials.Eye Contact Lens200329S759; discussion
S83–4, S192–4.12772737 [PubMed: 12772737]
25. Subbaraman LN, Glasier MA, Senchyna M, Sheardown H,
Jones L. Extraction efficiency of an extraction buffer used to
quantify lysozyme deposition on conventional and silicone
hydrogel contact lens materials. Eye Contact Lens 2007;
33:169-73. [PMID: 17630622]
26. Subbaraman LN, Glasier MA, Senchyna M, Jones L.
Stabilization of lysozyme mass extracted from lotrafilcon
silicone hydrogel contact lenses. Optom Vis Sci 2005;
82:209-14. [PMID: 15767876]
Molecular Vision 2008; 14:291-297 <http://www.molvis.org/molvis/v14/a36> © 2008 Molecular Vision
29627. Senchyna M, Jones L, Louie D, May C, Forbes I, Glasier MA.
Quantitative and conformational characterization of
lysozyme deposited on balafilcon and etafilcon contact lens
materials. Curr Eye Res 2004; 28:25-36. [PMID: 14704911]
28. Santos L, Rodrigues D, Lira M, Oliveira ME, Oliveira R, Vilar
EY, Azeredo J. The influence of surface treatment on
hydrophobicity, protein adsorption and microbial
colonisation of silicone hydrogel contact lenses. Cont Lens
Anterior Eye 2007; 30:183-8. [PMID: 17291818]
29. Suwala M, Glasier MA, Subbaraman LN, Jones L. Quantity and
conformation of lysozyme deposited on conventional and
silicone hydrogel contact lens materials using an in vitro
model. Eye Contact Lens 2007; 33:138-43. [PMID:
17502748]
30. Cheng L, Muller SJ, Radke CJ. Wettability of silicone-hydrogel
contact lenses in the presence of tear-film components. Curr
Eye Res 2004; 28:93-108. [PMID: 14972715]
31. Keith DJ, Christensen MT, Barry JR, Stein JM. Determination
of the lysozyme deposit curve in soft contact lenses. Eye
Contact Lens 2003; 29:79-82. [PMID: 12695708]
32. Bontempo AR, Rapp J. Protein and lipid deposition onto
hydrophilic contact lenses in vivo. CLAO J 2001; 27:75-80.
[PMID: 11352452]
33. Kidane A, Szabocsik JM, Park K. Accelerated study on
lysozyme deposition on poly(HEMA) contact lenses.
Biomaterials 1998; 19:2051-5. [PMID: 9870756]
34. Tan A, Milthorpe BK, Huff JW. A technique for quantitation of
protein deposits on rigid gas permeable contact lenses. CLAO
J 1997; 23:177-84. [PMID: 9240829]
35. Kingshott P, St John HA, Griesser HJ. Direct detection of
proteins adsorbed on synthetic materials by matrix-assisted
laser desorption ionization-mass spectrometry. Anal
Biochem 1999; 273:156-62. [PMID: 10469485]
36. Kingshott P, St John HA, Chatelier RC, Griesser HJ. Matrix-
assisted laser desorption ionization mass spectrometry
detection of proteins adsorbed in vivo onto contact lenses. J
Biomed Mater Res 2000; 49:36-42. [PMID: 10559744]
37. Russell WK, Park ZY, Russell DH. Proteolysis in mixed
organic-aqueous solvent systems: applications for peptide
mass mapping using mass spectrometry. Anal Chem 2001;
73:2682-5. [PMID: 11403317]
38. Carr S, Aebersold R, Baldwin M, Burlingame A, Clauser K,
Nesvizhskii A. The need for guidelines in publication of
peptide and protein identification data: Working Group on
Publication Guidelines for Peptide and Protein Identification
Data. Mol Cell Proteomics 2004; 3:531-3. [PMID: 15075378]
39. Baldwin MA. Protein identification by mass spectrometry:
issues to be considered. Mol Cell Proteomics 2004; 3:1-9.
[PMID: 14608001]
40. Ketelson HA, Meadows DL, Stone RP. Dynamic wettability
properties of a soft contact lens hydrogel. Colloids Surf B
Biointerfaces 2005; 40:1-9. [PMID: 15620833]
41. Garrett Q, Laycock B, Garrett RW. Hydrogel lens monomer
constituents modulate protein sorption. Invest Ophthalmol
Vis Sci 2000; 41:1687-95. [PMID: 10845587]
42. Prager MD, Quintana RP. Radiochemical studies on contact
lens soilation. I. Lens uptake of 14C-lysozyme from simple
and complex artificial tear solutions. J Biomed Mater Res
1997; 36:119-24. [PMID: 9212396]
43. Keith D, Hong B, Christensen M. A novel procedure for the
extraction of protein deposits from soft hydrophilic contact
lenses for analysis. Curr Eye Res 1997; 16:503-10. [PMID:
9154390]
44. Bontempo AR, Rapp J. Protein-lipid interaction on the surface
of a hydrophilic contact lens in vitro. Curr Eye Res 1997;
16:776-81. [PMID: 9255506]
45. Scott G, Mowrey-McKee M. Dimerization of tear lysozyme on
hydrophilic contact lens polymers. Curr Eye Res 1996;
15:461-6. [PMID: 8670747]
46. Sack RA, Sathe S, Hackworth LA, Willcox MD, Holden BA,
Morris CA. The effect of eye closure on protein and
complement deposition on Group IV hydrogel contact lenses:
relationship to tear flow dynamics. Curr Eye Res 1996;
15:1092-100. [PMID: 8950503]
47. Tsai PS, Evans JE, Green KM, Sullivan RM, Schaumberg DA,
Richards SM, Dana MR, Sullivan DA. Proteomic analysis of
human meibomian gland secretions. Br J Ophthalmol 2006;
90:372-7. [PMID: 16488965]
48. Li N, Wang N, Zheng J, Liu XM, Lever OW, Erickson PM, Li
L. Characterization of human tear proteome using multiple
proteomic analysis techniques. J Proteome Res 2005;
4:2052-61. [PMID: 16335950]
49. Zhou L, Huang LQ, Beuerman RW, Grigg ME, Li SF, Chew
FT, Ang L, Stern ME, Tan D. Proteomic analysis of human
tears: defensin expression after ocular surface surgery. J
Proteome Res 2004; 3:410-6. [PMID: 15253421]
50. Mannucci LL, Moro F, Cosani A, Palumbo M. Conformational
state of lacrimal proteins adsorbed on contact lenses. Curr Eye
Res 1985; 4:734-6. [PMID: 3861293]
51. Shi B, Isseroff RR. Arsenite pre-conditioning reduces UVB-
induced apoptosis in corneal epithelial cells through the anti-
apoptotic activity of 27 kDa heat shock protein (HSP27). J
Cell Physiol 2006; 206:301-8. [PMID: 16114012]
52. Fung KY, Morris C, Sathe S, Sack R, Duncan MW.
Characterization of the in vivo forms of lacrimal-specific
proline-rich proteins in human tear fluid. Proteomics 2004;
4:3953-9. [PMID: 15526346]
53. Dickinson DP, Thiesse M. A major human lacrimal gland
mRNA encodes a new proline-rich protein family member.
Invest Ophthalmol Vis Sci 1995; 36:2020-31. [PMID:
7544782]
54. Barka T, Asbell PA, van der Noen H, Prasad A. Cystatins in
human tear fluid. Curr Eye Res 1991; 10:25-34. [PMID:
2029847]
Molecular Vision 2008; 14:291-297 <http://www.molvis.org/molvis/v14/a36> © 2008 Molecular Vision
The print version of this article was created on 8 February 2008. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
297